Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Pfizer’s high-profile, high-volatility Covid-19 franchise stabilized at the end of 2024, as the New York drugmaker pursues a revamp of its R&D operations and continues
Regeneron Pharmaceuticals, one of the original and longest-standing biotech companies, is entering the dividends arena for the first time. The Tarrytown, NY-based drugmaker surprised the
Physicians have launched a legal challenge against the Office of Personnel Management (OPM) and federal health agencies for removing webpages from health-related websites. Doctors for
A hydroablation device for benign prostatic hyperplasia showed promise as a potential treatment aid for early prostate cancer in a small Chinese study. The proportion
Sen. Bill Cassidy, MD (R-La.), said he received numerous pledges from Robert F. Kennedy Jr. and the Trump administration to protect medicine and science —
Amid a political environment in which government websites are being gutted of vital health information, the American College of Obstetricians and Gynecologists (ACOG) has stepped
Jeremy Faust is editor-in-chief of MedPage Today, an emergency medicine physician at Brigham and Women’s Hospital in Boston, and a public health researcher. He is
Studies censored by government employees will have a tough time getting published in the American Journal of Public Health (AJPH), the journal’s leadership said during
Modifying the quadruplet regimen of isatuximab, bortezomib, lenalidomide, and dexamethasone could allow older, frail patients with transplant-ineligible multiple myeloma to benefit from the therapy. The